Chemokine receptor CCR2b 641 polymorphism and its relation to CD4 T-cell counts and disease Progression in a Danish cohort of HIV-infected individuals

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 2, 1998, Pages 110-116

  Eugen Olsen, Jesper ^a   Iversen, Astrid K N ^b   Benfield, Thomas L ^a   Koppelhus, Uffe ^a   Garred, Peter ^b  

^a Mental Health Services CPH   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

CCR2; CCR5; CD4+ T cells; Chemokine receptors; Disease progression; HIV 1

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; HELPER CELL; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS RESISTANCE;

ALLELES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DENMARK; DISEASE PROGRESSION; DNA PRIMERS; GENE FREQUENCY; HIV INFECTIONS; HIV-1; HUMANS; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; RECEPTORS, CYTOKINE; SURVIVAL RATE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032104091     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199806010-00002     Document Type: Article

References (19)

1. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
2. Deng H, Liu R, Ellmeier W, et al. Identification of a major coreceptor for primary isolates of HIV-1 [see comments]. Nature 1996;381:661-6.
3. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
4. McNicholl JM, Smith DK, Qari SH, Hodge T. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele (32 CCR5). Emerg Infect Dis 1997;3:261-71.
5. Quillent C, Oberlin E, Braun J, et al. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 1998;351:14-18.
6. Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185:1681-91.
7. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
8. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-58.
9. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997;277:959-65.
10. Michael NL, Louie LG, Rohrbaugh AM, et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med 1997;3:1160-2.
11. Katzenstein T, Eugen-Olsen J, Iversen AK, et al. HIV-infected individuals with the CKR5/CKR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of infection than do patients with the wildtype. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:10-14.
12. Eugen-Olsen J, Iversen AK, Garred P, et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997;11:305-10.
13. Garred P, Eugen-Olsen J, Iversen AK, Benfield TL, Svejgaard A, Hofmann B. Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group. Lancet 1997; 349:1884.
14. Smith MW, Dean M, Carrington M, Huttley GA, O'Brien SJ. CCR5-delta 32 gene deletion in HIV-1 infected patients. Lancet 1997;350:741-2.
15. Michael NL, Louie LG, Sheppard HW. CCR5-delta 32 gene deletion in HIV-1 infected patients. Lancet 1997;350:741-2.
16. Garred P. Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis. Lancet 1998;351:2-3.
17. Meyer L, Magierowska M, Hubert JB, et al., and the SEROCO study group. Early protective effect of CCR5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS 1997;11:F73-8.
18. Rana S, Besson G, Cook DG, et al. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation. J Virol 1997;71:3219-27.
19. Smith MW, Carrington M, Winkler C, et al. CCR2 chemokine receptor and AIDS progression. Nat Med 1997;3:1052-3.